Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2654 |
|
| Actual shortage: | 249 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2396 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
36 (14%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-CEPHALEXIN 125 | 125MG | POWDER FOR SUSPENSION | Resolved | 2023-07-04 | 2023-10-03 | 197282 |
| TEVA-CLOXACILLIN | 500MG | CAPSULE | Resolved | 2023-07-13 | 2023-10-03 | 198587 |
| TEVA-CLOXACILLIN | 125MG | GRANULES FOR SOLUTION | Resolved | 2023-06-19 | 2023-10-03 | 195518 |
| TEVA-FUROSEMIDE | 20MG | TABLET | Resolved | 2023-07-20 | 2023-10-03 | 199284 |
| TEVA-LACTULOSE | 667MG | SOLUTION | Resolved | 2023-06-20 | 2023-10-03 | 195766 |
| CALMYLIN | 125MG 12.5MG 3.33MG | SYRUP | Resolved | 2023-06-20 | 2023-10-03 | 195836 |
| CALMYLIN | 125MG 12.5MG 3.33MG | SYRUP | Resolved | 2023-01-12 | 2023-10-03 | 180888 |
| CALMYLIN | 125MG 12.5MG 3.33MG | SYRUP | Resolved | 2023-06-20 | 2023-10-03 | 195769 |
| NEO-LARYNGOBIS | 135MG | SUPPOSITORY | Resolved | 2023-06-16 | 2023-10-03 | 195198 |
| ACT TERBINAFINE | 250MG | TABLET | Resolved | 2020-04-10 | 2023-10-03 | 111874 |
| ZOLEDRONIC ACID FOR INJECTION | 4MG | SOLUTION | Resolved | 2020-06-11 | 2023-10-03 | 117593 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2023-06-16 | 2023-10-03 | 195103 |
| EPIRUBICIN FOR INJECTION | 2MG | SOLUTION | Resolved | 2023-06-08 | 2023-10-03 | 194144 |
| TEVA-LISINOPRIL/HCTZ (TYPE Z) | 12.5MG 10MG | TABLET | Resolved | 2023-07-18 | 2023-10-03 | 199103 |
| TEVA-MIRTAZAPINE | 30MG | TABLET | Resolved | 2023-06-08 | 2023-10-03 | 194100 |
| TEVA-RISPERIDONE | 0.5MG | TABLET | Resolved | 2017-03-13 | 2023-10-03 | 1566 |
| TEVA-NITROFURANTOIN | 50MG | CAPSULE | Resolved | 2023-08-17 | 2023-10-03 | 202246 |
| TEVA-CEPHALEXIN | 250MG | CAPSULE | Resolved | 2022-10-28 | 2023-10-03 | 173007 |
| TEVA-ROPINIROLE | 2MG | TABLET | Resolved | 2021-07-08 | 2023-09-24 | 142178 |
| TEVA-ROPINIROLE | 1MG | TABLET | Resolved | 2021-07-08 | 2023-09-22 | 142175 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-FUROSEMIDE | 20MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14039 |
| LEUCOVORIN CALCIUM INJECTION | 10MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14036 |
| GEMCITABINE FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14033 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |
| EPTIFIBATIDE INJECTION | 2MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14027 |
| EPTIFIBATIDE INJECTION | 0.75MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14024 |
| CLOXACILLIN SODIUM FOR INJECTION | 2G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14021 |
| CLOXACILLIN SODIUM FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14018 |
| CLOXACILLIN SODIUM FOR INJECTION | 500MG | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14014 |
| TEVA-PRAMIPEXOLE | 1.5MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14007 |